First-line brentuximab vedotin plus chemotherapy improves overall survival in patients with stage III/IV classical Hodgkin Lymphoma: An updated analysis of ECHELON-1 Meeting Abstract
| Authors: | Straus, D.; Radford, J.; Connors, J.; Kim, W. S.; Gallamini, A.; Ramchandren, R.; Friedberg, J.; Advani, R.; Hutchings, M.; Evens, A.; Smolewski, P.; Savage, K.; Bartlett, N.; Eom, H. S.; Abramson, J.; Dong, C.; Campana, F.; Fenton, K.; Puhlmann, M.; Ansell, S. |
| Abstract Title: | First-line brentuximab vedotin plus chemotherapy improves overall survival in patients with stage III/IV classical Hodgkin Lymphoma: An updated analysis of ECHELON-1 |
| Meeting Title: | 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | overall survival; chemotherapy; lymphoma; phase iii; brentuximab vedotin; classical hodgkin; hl; echelon-1 |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Sep 28-Oct 1 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S350 |
| Language: | English |
| ACCESSION: | WOS:000897948100362 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(22)01483-5 |
| Notes: | Meeting Abstract: HL-507 -- Source: Wos |
